| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Moderna, Inc. (MRNA) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 34 sells. MRNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.18M | $368.35M | - | |
| Other | 54.5K | $3.25M | - | |
| CFO | 44.7K | $2.66M | - | |
| Pres | 37.2K | $2.22M | -53,336 | |
| Dir | 1.5K | $91.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | Hoge Stephen74 | President | Sale+OE | 341 | $144.50 | $49,276.10 | - | -46.6% | -81.8% | |
| May 29, 2024 | Mock James M85 | Chief Financial Officer | Sale+OE | 183 | $144.50 | $26,444.36 | -3.0% | -46.6% | -81.8% | |
| May 29, 2024 | Klinger Shannon Thyme81 | Chief Legal Officer | Sale+OE | 183 | $144.50 | $26,444.36 | -1.7% | -46.6% | -81.8% | |
| May 28, 2024 | Mock James M85 | Chief Financial Officer | Sale+OE | 648 | $162.47 | $105,282.89 | -10.2% | -46.7% | -83.0% | |
| May 28, 2024 | Klinger Shannon Thyme81 | Chief Legal Officer | Sale+OE | 1,296 | $162.47 | $210,565.79 | -10.9% | -46.7% | -83.0% | |
| May 22, 2024 | Afeyan Noubar74 | Director | Sell | 15,000 | $157.57 | $2,363,555.75 | - | -46.8% | -83.6% | |
| May 15, 2024 | Afeyan Noubar74 | Director | Sell | 15,000 | $127.32 | $1,909,863.08 | -0.1% | -35.8% | -81.7% | |
| May 15, 2024 | Hoge Stephen74 | President | Sell | 15,000 | $127.49 | $1,912,350.00 | -1.0% | -35.8% | -81.7% | |
| May 10, 2024 | Hoge Stephen74 | President | Sale+OE | 255 | $120.96 | $30,844.11 | - | -28.1% | -79.3% | |
| May 8, 2024 | Afeyan Noubar74 | Director | Sell | 15,000 | $121.68 | $1,825,220.27 | -0.2% | -32.5% | -80.0% |